| Texto completo | |
| Autor(es): |
Charles, Charles M'Poca
;
Munezero, Aline
;
Bahamondes, Luis G.
;
Pacagnella, Rodolfo C.
Número total de Autores: 4
|
| Tipo de documento: | Artigo Científico |
| Fonte: | EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE; v. 27, n. 2, p. 6-pg., 2022-02-11. |
| Resumo | |
Objective The aim of the study was to assess the impact of the COVID-19 pandemic on sales of modern contraceptive methods in Brazil. Methods Monthly sales data were analysed of short-acting reversible contraceptive methods and long-acting reversible contraceptive (LARC) methods (implants and intrauterine contraception) and COVID-19 related deaths. Contraceptive methods were grouped as follows: emergency contraception (EC); oral contraception, vaginal rings and transdermal patches; injectable contraception; LARC methods including the copper intrauterine device (Cu-IUD); and LARC methods excluding the Cu-IUD. Results Contraceptive sales showed a non-significant increase in 2020 compared with the previous year; average sales ranged from 12.8 to 13.0 million units per month. Sales of injectable contraceptives increased between March and June 2020 and EC pills between June and July 2020; the variation in sales of pills, patches and rings was not significant. Sales of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the etonogestrel (ENG) implant showed three patterns: a decrease in sales between February and May 2020 (coinciding with the closure of family planning services), an increase in sales after May 2020 (coinciding with the first COVID-19-related deaths), and a further increase in sales after July 2020 (corresponding to the increasing number of deaths from COVID-19). Conclusion The COVID-19 pandemic has disrupted the Brazilian health care system. Since many family planning clinics were closed, sales of most modern contraceptives fell during 2020; however, the increase in sales of the LNG-IUS and ENG implant in the private sector indicates inequitable access to modern contraceptive methods. (AU) | |
| Processo FAPESP: | 15/20504-9 - Manifestações clínicas de usuárias de contraceptivos de somente progestogênios |
| Beneficiário: | Luis Guillermo Bahamondes |
| Modalidade de apoio: | Auxílio à Pesquisa - Temático |